Ozempic vs Wegovy: Which Is Right for You?
A detailed side-by-side comparison of Ozempic and Wegovy, including cost, side effects, dosing, and provider availability.
At a Glance
Ozempic
FDA ApprovedWegovy
FDA ApprovedDetailed Comparison
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active Ingredient | semaglutide | semaglutide |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| FDA Approved | Yes | Yes |
| FDA Indication | Type 2 Diabetes (off-label for weight loss) | Chronic weight management |
| Dosing Schedule | Once weekly | Once weekly |
| Administration | Subcutaneous injection (pen) | Subcutaneous injection (pen) |
| Starting Price (lowest provider) | N/A | N/A |
| Provider Count | 16 | 19 |
| Insurance Coverage | 10 providers | 12 providers |
| Weight Loss Data | In the STEP trials, patients taking semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo. Ozem... | The STEP 1 trial showed patients on Wegovy lost an average of 14.9% of body weight (about 33 lbs) over 68 weeks. In the STEP 3 trial, which combined W... |
How They Compare
Ozempic and Wegovy both contain semaglutide and work through the same GLP-1 receptor agonist mechanism. The primary differences are in their FDA indications and dosing. Ozempic is indicated for type 2 diabetes (off-label for weight loss), while Wegovy is indicated for chronic weight management. Both are manufactured by Novo Nordisk and have demonstrated significant clinical results in weight management.
Side Effects Comparison
Ozempic
Common
- Nausea (most common, usually improves over time)
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Injection site reactions
Serious (Rare)
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems
- Kidney problems
- Allergic reactions
- Thyroid tumors (boxed warning based on animal studies)
- Diabetic retinopathy complications
Wegovy
Common
- Nausea (44% of patients, usually temporary)
- Diarrhea (30%)
- Vomiting (24%)
- Constipation (24%)
- Abdominal pain
- Headache
- Fatigue
Serious (Rare)
- Pancreatitis
- Gallbladder problems
- Kidney injury
- Suicidal thoughts (rare, under investigation)
- Thyroid C-cell tumors (boxed warning, animal studies)
- Hypoglycemia when combined with insulin
Dosing Schedule Comparison
Ozempic
Subcutaneous injection (pen) - Once weekly
Wegovy
Subcutaneous injection (pen) - Once weekly
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?
Ozempic (Semaglutide) is made by Novo Nordisk and is FDA-approved. Wegovy (Semaglutide) is made by Novo Nordisk and is FDA-approved. Both contain the same active ingredient (semaglutide) but differ in manufacturing, dosing, and FDA indication.
Which is more affordable, Ozempic or Wegovy?
Based on available providers, Ozempic starts at $0/month while Wegovy starts at $0/month. Both have similar starting prices. Actual costs depend on your provider, insurance coverage, and dose level.
Which is more effective for weight loss, Ozempic or Wegovy?
Both medications have shown significant weight loss results. Since both contain semaglutide, weight loss results should be comparable at equivalent doses. Your healthcare provider can help determine which is best for your specific situation.
Can I switch from Ozempic to Wegovy?
Switching between GLP-1 medications is possible but should always be done under medical supervision. Your provider will determine the appropriate starting dose for the new medication and may adjust the transition schedule based on your current dose and response. Since both contain the same active ingredient, the transition may be more straightforward.
Related Comparisons
Medical Disclaimer: This comparison is for educational purposes only and should not replace professional medical advice. Individual results vary. Always consult your healthcare provider before starting or changing any medication.